377 results on '"Pavord, Sue"'
Search Results
2. Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019
3. Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis
4. The psychiatric and psychological sequelae of vaccine-induced immune thrombotic thrombocytopenia (VITT)
5. Clinical picture of VITT
6. Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
7. White blood cells in pregnancy: reference intervals for before and after delivery
8. Haematology of pregnancy
9. Anti‐platelet factor 4 immunothrombotic syndromes.
10. Kidney Transplantation From Deceased Donors With Vaccine-induced Immune Thrombocytopenia and Thrombosis: An Updated Analysis of the UK Experience
11. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study
12. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
13. Updated international consensus report on the investigation and management of primary immune thrombocytopenia
14. Interest and barriers to research in obstetric haematology – findings from a national survey in the United Kingdom
15. Qualitative study of the consequences of vaccine-induced immune thrombocytopenia and thrombosis: the experiences of family members
16. Reassurance on bleeding and thrombotic events following second dose BNT162b2 and ChAdOx1 COVID-19 vaccines
17. PB2612: UNITED KINGDOM RETROSPECTIVE OBSERVATIONAL STUDY OF ROMIPLOSTIM AND OTHER TREATMENTS IN EARLY IMMUNE THROMBOCYTOPENIA
18. Haematology of pregnancy
19. Living with vaccine-induced immune thrombocytopenia and thrombosis: a qualitative study
20. Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura
21. Clear and present danger: Mechanical heart valves in pregnancy
22. Revisiting the basis for haemoglobin screening in pregnancy
23. Hematological Assessment of a Patient with an Inherited Bleeding Disorder
24. Haematological Problems in Pregnancy
25. COVID‐19‐related adrenal haemorrhage: Multicentre UK experience and systematic review of the literature
26. How I treat postpartum hemorrhage
27. Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients
28. Drug‐induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data
29. Retrospective, Observational, Multicenter Study Assessing the Thrombopoietin Receptor Agonist (TPO-RA) Romiplostim and Other Treatments for Patients with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in the United Kingdom (UK)
30. European guidelines on perioperative venous thromboembolism prophylaxis: Patients with preexisting coagulation disorders and after severe perioperative bleeding
31. Dosing of intravenous immunoglobulin in COVID-19 vaccine-induced immune thrombocytopenia and thrombosis
32. Maternal iron deficiency anaemia in pregnancy: Lessons from a national audit
33. Haematology of pregnancy
34. HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
35. Drug‐induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data.
36. A case of ChAdOx1 vaccine-induced thrombocytopenia and thrombosis syndrome leading to bilateral adrenal haemorrhage and adrenal insufficiency
37. Obstetrics, Contraception, and Estrogen Replacement
38. Obstetric haematology
39. Haematological conditions
40. Rare missense variants in Tropomyosin‐4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding
41. Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
42. Bleeding and thrombotic complications of kidney disease
43. Second-dose VITT: rare but real
44. Passenger lymphocyte syndrome following small bowel transplantation
45. Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources: Response to Comment from Yamada et al
46. Organ transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia
47. Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination
48. VITT and Second Doses of Covid-19 Vaccine
49. Gynecologic Conditions and Anemia: What Can We Do About Iron Deficiency Anemia in Women?
50. Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.